Insider Transactions Reported by 20 Insiders of Akebia Therapeutics, Inc.

Symbol
AKBA on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Akebia Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John P. Butler CEO and President, Director $4,434,328 -$387,826 -8% 04 Mar 2026
Steven K. Burke SVP, Chief Medical Officer $1,318,320 -$94,045 -6.7% 02 Feb 2026
Erik Ostrowski SVP, CFO, CBO & Treasurer $934,962 -$200,204 -18% 02 Feb 2026
Ellen Snow SVP, CFO and Treasurer $872,424 31 Jan 2024
Michel Dahan SVP, Chief Operating Officer $846,836 13 May 2024
Nicole R. Hadas SVP, Chief Legal Officer $820,566 13 May 2024
Carolyn M. Rucci SVP, Chief Legal Officer $817,845 -$96,983 -11% 02 Feb 2026
Nicholas Grund Chief Commercial Officer $780,832 -$117,912 -13% 02 Feb 2026
David A. Spellman SVP, CFO and Treasurer $546,004 16 May 2023
Adrian Adams Director $525,310 10 Jun 2025
Michael W. Rogers Director $423,729 10 Jun 2025
Cynthia Smith Director $421,644 10 Jun 2025
Richard C. Malabre SVP, Chief Accounting Officer $416,152 -$176,057 -30% 02 Feb 2026
Steven C. Gilman Director $400,414 10 Jun 2025
Myles Wolf Director $349,458 10 Jun 2025
Ron Frieson Director $339,290 10 Jun 2025
LeAnne M. Zumwalt Director $286,628 10 Jun 2025
Violetta Cotreau SVP, Chief Accounting Officer $268,982 12 May 2022
Dell J. Faulkingham Svp, Cco $212,590 28 Feb 2022
Michael Thomas Heffernan Director $59,416 02 Jun 2021

Recent Insider Transactions by Companies or Individuals for Akebia Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
John P. Butler AKBA Common Stock Purchase 2.1% $86,588 $1.25 69,270 3,367,064 04 Mar 2026 Direct
Carolyn M. Rucci AKBA Common Stock Sale -10.6% $96,983 $1.39 -69,772 588,378 02 Feb 2026 Direct
Richard C. Malabre AKBA Common Stock Sale -14.2% $68,838 $1.39 -49,524 299,390 02 Feb 2026 Direct
Erik Ostrowski AKBA Common Stock Sale -4.94% $48,582 $1.39 -34,951 672,635 02 Feb 2026 Direct
Nicholas Grund AKBA Common Stock Sale -13.1% $117,912 $1.39 -84,829 561,750 02 Feb 2026 Direct
Steven K. Burke AKBA Common Stock Sale -6.66% $94,045 $1.39 -67,658 948,432 02 Feb 2026 Direct
John P. Butler AKBA Common Stock Award 5.47% 175,250 3,381,483 02 Feb 2026 Direct
John P. Butler AKBA Common Stock Sale -9.62% $474,414 $1.39 -341,305 3,206,233 02 Feb 2026 Direct
Carolyn M. Rucci AKBA Common Stock Award 40.6% 190,000 658,150 30 Jan 2026 Direct
Carolyn M. Rucci AKBA Stock Option (Right to buy) Award 270,000 270,000 30 Jan 2026 Direct
Richard C. Malabre AKBA Common Stock Award 29.3% 79,000 348,914 30 Jan 2026 Direct
Richard C. Malabre AKBA Stock Option (Right to buy) Award 119,000 119,000 30 Jan 2026 Direct
Erik Ostrowski AKBA Common Stock Award 40.5% 204,000 707,586 30 Jan 2026 Direct
Erik Ostrowski AKBA Stock Option (Right to buy) Award 320,000 320,000 30 Jan 2026 Direct
Nicholas Grund AKBA Common Stock Award 46.1% 204,000 646,579 30 Jan 2026 Direct
Nicholas Grund AKBA Stock Option (Right to buy) Award 320,000 320,000 30 Jan 2026 Direct
Steven K. Burke AKBA Common Stock Award 25.1% 204,000 1,016,090 30 Jan 2026 Direct
Steven K. Burke AKBA Stock Option (Right to buy) Award 320,000 320,000 30 Jan 2026 Direct
John P. Butler AKBA Common Stock Award 27.3% 743,000 3,463,849 30 Jan 2026 Direct
John P. Butler AKBA Stock Option (Right to buy) Award 1,115,000 1,115,000 30 Jan 2026 Direct
Erik Ostrowski AKBA Common Stock Sale -7.58% $151,622 $3.67 -41,314 503,586 30 Jun 2025 Direct
LeAnne M. Zumwalt AKBA Common Stock Award 48.4% 35,700 109,400 10 Jun 2025 Direct
LeAnne M. Zumwalt AKBA Stock Option (Right to buy) Award 53,600 53,600 10 Jun 2025 Direct
Adrian Adams AKBA Common Stock Award 21.7% 35,700 200,500 10 Jun 2025 Direct
Adrian Adams AKBA Stock Option (Right to buy) Award 53,600 53,600 10 Jun 2025 Direct
Myles Wolf AKBA Common Stock Award 36.6% 35,700 133,381 10 Jun 2025 Direct
Myles Wolf AKBA Stock Option (Right to buy) Award 53,600 53,600 10 Jun 2025 Direct
Cynthia Smith AKBA Common Stock Award 28.5% 35,700 160,933 10 Jun 2025 Direct
Cynthia Smith AKBA Stock Option (Right to buy) Award 53,600 53,600 10 Jun 2025 Direct
Michael W. Rogers AKBA Common Stock Award 28.3% 35,700 161,729 10 Jun 2025 Direct
Michael W. Rogers AKBA Stock Option (Right to buy) Award 53,600 53,600 10 Jun 2025 Direct
Steven C. Gilman AKBA Common Stock Award 30.5% 35,700 152,830 10 Jun 2025 Direct
Steven C. Gilman AKBA Stock Option (Right to buy) Award 53,600 53,600 10 Jun 2025 Direct
Ron Frieson AKBA Common Stock Award 38.1% 35,700 129,500 10 Jun 2025 Direct
Ron Frieson AKBA Stock Option (Right to buy) Award 53,600 53,600 10 Jun 2025 Direct
Richard C. Malabre AKBA Common Stock Sale -5.32% $60,150 $4.01 -15,000 266,914 09 Jun 2025 Direct
Richard C. Malabre AKBA Common Stock Options Exercise 5.62% 15,000 281,914 09 Jun 2025 Direct
Richard C. Malabre AKBA Stock Option (Right to buy) Options Exercise -4.46% -15,000 321,000 09 Jun 2025 Direct
Richard C. Malabre AKBA Common Stock Sale -4.76% $47,069 $3.53 -13,334 266,914 04 Jun 2025 Direct
John P. Butler AKBA Common Stock Sale -1.78% $84,928 $1.83 -46,409 2,557,921 03 Mar 2025 Direct
Steven K. Burke AKBA Common Stock Sale -0.88% $13,074 $1.83 -7,144 809,090 03 Mar 2025 Direct
John P. Butler AKBA Common Stock Sale -5.25% $302,925 $2.10 -144,250 2,604,330 03 Feb 2025 Direct
Steven K. Burke AKBA Common Stock Sale -5.83% $106,063 $2.10 -50,506 816,234 03 Feb 2025 Direct
Richard C. Malabre AKBA Common Stock Sale -9.73% $63,424 $2.10 -30,202 280,248 03 Feb 2025 Direct
Nicholas Grund AKBA Common Stock Sale -11.2% $116,804 $2.10 -55,621 442,579 03 Feb 2025 Direct
John P. Butler AKBA Common Stock Award 34.2% 701,000 2,748,580 31 Jan 2025 Direct
John P. Butler AKBA Stock Option (Right to buy) Award 1,051,400 1,051,400 31 Jan 2025 Direct
John P. Butler AKBA Performance Stock Units Award 350,500 350,500 31 Jan 2025 Direct
Steven K. Burke AKBA Common Stock Award 29% 194,900 866,740 31 Jan 2025 Direct
Steven K. Burke AKBA Stock Option (Right to buy) Award 292,300 292,300 31 Jan 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.